ClinicalTrials.Veeva

Menu

Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring

Johns Hopkins University logo

Johns Hopkins University

Status and phase

Completed
Phase 4

Conditions

Pain

Treatments

Drug: Fentanyl

Study type

Interventional

Funder types

Other

Identifiers

NCT01327677
NA_00029336

Details and patient eligibility

About

This research is being done to compare two methods of giving fentanyl, a narcotic often given to patients following brain surgery and determine if one method has more side effects than the other. Both of these methods are available in the postoperative treatment of pain. This research also is being done to determine if patients receiving narcotic pain medicine will benefit from additional monitoring of carbon dioxide levels. Since narcotic pain medicines can slow down breathing, The investigators want to see if measuring exhaled carbon dioxide levels will help identify a slower breathing rate and improve safety.

Full description

See brief summary

Enrollment

137 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult male and female, English speaking patients undergoing supratentorial craniotomy for tumor under general anesthesia at the Johns Hopkins Hospital will be eligible for this study.

Exclusion criteria

  • pregnant women

  • patients with post operative neurological changes

  • patients who remain intubated post-operatively

  • patients who require the use of concomitant administration of sedatives

    • patients who are unable to initiate a PCA bolus
    • patients who are unable to communicate verbally
    • patients who are allergic to fentanyl
  • patients who have a history of narcotic abuse

  • patients who have a history of chronic pain requiring opioids

  • patients who have been in any investigational drug trial within 1 month of the treatment day

  • patients who have chronic respiratory insufficiency

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

137 participants in 2 patient groups

Pro re nata (PRN) fentanyl
Active Comparator group
Description:
A nurse can give the patient up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Treatment:
Drug: Fentanyl
Drug: Fentanyl
Intravenous Patient-controlled Analgesia (IVPCA) fentanyl
Active Comparator group
Description:
Fentanyl will be given with a Patient Controlled Analgesia (PCA) pump.
Treatment:
Drug: Fentanyl
Drug: Fentanyl

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems